---
document_datetime: 2026-01-08 12:57:00
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/wayrilz-epar-all-authorised-presentations_en.pdf
document_name: wayrilz-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8330473
conversion_datetime: 2026-01-10 10:56:56.319862
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.1
  docling: 2.67.0
  docling-core: 2.58.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging     | Pack size                        |
|------------------|-------------------|------------|-----------------------|---------------------------|-------------------------|----------------------------------|
| EU/1/25/1974/001 | WAYRILZ           | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu) | 28 tablets                       |
| EU/1/25/1974/002 | WAYRILZ           | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu) | 56 (2 x 28) tablets (multipack)  |
| EU/1/25/1974/003 | WAYRILZ           | 400 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/alu) | 196 (7 x 28) tablets (multipack) |